Alumis ALMS
NASDAQ ALMS
$7.90 +0.13 (+1.67%)
At close: Sep 21, 2026 · 4:00 PM EDT

Alumis (ALMS) Asset Writedowns and Impairment (2026)

Alumis' (ALMS) quarterly Asset Writedowns and Impairment came in at $41.8 million in Q2 2026.

Analysis

Alumis (ALMS) Asset Writedowns and Impairment (2026) Analysis & Trends

Alumis (ALMS) has reported Asset Writedowns and Impairment for 1 consecutive years, with $41.8 million the latest figure, recorded in Q2 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn
10 Alumis 966.94 Mn 464.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.82 Mn
API Access

Alumis Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ALMS&period=max&api_key=YOUR_API_KEY